The cost-effectiveness of screening the U.S. blood supply for West Nile virus

Annals of Internal Medicine

Volumn 143, Issue 7, 2005, Pages

  Custer, Brian ^a   Busch, Michael P ^b   Marfin, Anthony A ^b   Petersen, Lyle R ^b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; EPIDEMIC; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

EID: 25444497225     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-7-200510040-00007     Document Type: Article

References (27)

1. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Sally C, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760-68. [PMID: 15317889]
2. Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion. 2003;43:721-29. [PMID: 12757522]
3. Marshall DA, Weinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang. 2004;86:28-40. [PMID: 14984557]
4. Weinstein MC, Fineberg HC. Clinical Decision Analysis. Philadelphia: WB Saunders; 1980.
5. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002;22:417-30. [PMID: 12365484]
6. Hoffer S, Berardino F, Smith J, Rubin S. Economic values for evaluation of FAA investment and regulatory decisions. Publication FAA-APO-98-8. 1998. Federal Aviation Administrarion, Office of Aviation Policy, Plans, and Management Analysis. Accessed at www.api.faa.gov/economic/742SECT2.pdf on 3 March 2003.
7. Workshop on development of donor screening assays for West Nile virus. 4 November 2002. U.S. Department of Health and Human Services. Center for Biologies Evaluation and Research, Food and Drug Administration. Accessed at www.fda.gov/cber/minutes/wnv110402.pdf on 10 May 2005.
8. Draft guidance for industry: assessing donor suitability and blood and blood product safety in cases of known of suspected West Nile virus infection. 14 April 2005. U.S. Department of Health and Human Services, Center for Biologies Evaluation and Research, U.S. Food and Drug Administration. Accessed at www.fda.gov/gdlns/wnvguid2.htm on 12 May 2005.
9. Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, et al. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience. Transfusion. 2005;45:469-79. [PMID: 15819665]
10. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348:2196-203. [PMID: 12773646]
11. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236-45. [PMID: 14500806]
12. Detection of West Nile virus in blood donations-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:769-72. [PMID: 12917583]
13. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004;44:1547-54. [PMID: 15504158]
14. AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion. 1997;37:45-51. [PMID: 9024489]
15. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion. 1993;33:544-51. [PMID: 8333017]
16. Birkmeyer JD, AuBuchon JP, Littenberg B, O'Connor GT, Nease RF Jr, Nugent WC, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg. 1994;57:161-68. [PMID: 8279884]
17. Jackson BR, Umlas J, AuBuchon JP. The cost-effectiveness of postoperative recovery of RBCs in preventing transfusion-associated virus transmission after joint arthroplasty. Transfusion. 2000;40:1063-66. [PMID: 10988307]
18. Wallace EL, Churchill WH, Surgenor DM, Cho GS, McGurk S. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion. 1998;38:625-36. [PMID: 9683100]
19. Busch MP, Caglioti S, Robertson GF, McAuley JD, Tobler LH, Kamel H, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005;[In press].
20. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus in United States blood donors, 2003 and 2004. N Engl J Med. 2005: [In press].
21. Zohrabian A, Meltzer MI, Ratard R, Billah K, Molinari NA, Roy K, et al. West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis. 2004;10:1736-44. [PMID: 15504258]
22. Consumer Price Index. U.S. Department of Labor. Bureau of Labor Statistics. 2004. Accessed at http://stats.bls.gov/cpi on 24 May 2004.
23. Grosse SD. Productivity loss tables. In: Haddix AC, Teutsch SM, Corso PS, eds. Prevention Effectiveness. 2nd ed. New York: Oxford Univ Pr; 2003:245-57.
24. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies. Recommendations from the Panel on Cost Effectiveness in Health and Medicine. Panel on Cost Effectiveness in Health and Medicine. Pharmacoeconomics. 1997;11:159-68. [PMID: 10172935]
25. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276:1253-58. [PMID: 8849754]
26. Llewelyn C, Amin M, Malfroy M, Williamson L. Distribution of blood component recipients according to immune status. Presented at Eurosat on 19 October 2004. Transfusion Clinque et Biologique. Accessed at www.ints.fr/pdf/ sat04_09_llewelyn.pdf on 15 March 2005.
27. Petersen LR, Hayes EB. Westward ho? The spread of West Nile virus. N Engl J Med. 2004;351:2257-59. [PMID: 15564540]